Age And Allocation Of Adjuvant Treatments
A recent article "Aging a Decade in a Day: Age cutoff bias in adjuvant therapy allocation for early-stage breast cancer" explores the issue of age bias in the allocation of adjuvant therapy for early-stage breast cancer patients. Adjuvant therapy is a type of cancer...
What is the Oncotype DX test and how is it used to improve breast cancer outcomes?
Oncotype DX is a genetic test that can help predict the likelihood of breast cancer recurrence in women with early-stage, hormone-receptor-positive, HER2-negative breast cancer. It can be used to guide treatment decisions, and potentially spare some women from unnecessary chemotherapy. It is an important tool for personalising breast cancer treatment and improving patient outcomes.
Breast screening, mammograms and implants
Breast screening using mammograms can detect breast cancer at a very early stage and is offered to women aged 50-70 every 3 years on the NHS. In some countries, such as the USA, breast screening starts at age 40 and is recommended yearly. Breast screening reduces the...
One Step Nucleic Acid (OSNA) intraoperative assessment of sentinel lymph node biopsy at Arden Breast Clinic
Sentinel lymph node biopsy is routinely performed during breast cancer surgery. This is the analysis of the first lymph node in the underarm to check if cancer has spread or not. In some breast cancer units, it may take up to 4 weeks to process the sentinel node in...